Control of Type I Error Rates in Bayesian Sequential Designs
暂无分享,去创建一个
[1] Bradley P Carlin,et al. Hierarchical Commensurate and Power Prior Models for Adaptive Incorporation of Historical Information in Clinical Trials , 2011, Biometrics.
[2] B. Efron. Bayesians, Frequentists, and Scientists , 2005 .
[3] James O. Berger,et al. Statistical Analysis and the Illusion of Objectivity , 1988 .
[4] S. Pocock. Group sequential methods in the design and analysis of clinical trials , 1977 .
[5] Donald A. Berry,et al. Simulation-based sequential Bayesian design , 2007 .
[6] J. Wason,et al. A Bayesian adaptive design for biomarker trials with linked treatments , 2015, British Journal of Cancer.
[7] KyungMann Kim. Group Sequential Methods with Applications to Clinical Trials , 2001 .
[8] P. Müller,et al. Determining the Effective Sample Size of a Parametric Prior , 2008, Biometrics.
[9] D. Heitjan,et al. Bayesian interim analysis of phase II cancer clinical trials. , 1997, Statistics in medicine.
[10] Donald A. Berry,et al. Group sequential clinical trials: a classical evaluation of Bayesian decision-theoretic designs , 1994 .
[11] G L Rosner,et al. A Bayesian group sequential design for a multiple arm randomized clinical trial. , 1995, Statistics in medicine.
[12] Christopher Jennison,et al. Group Sequential Analysis Incorporating Covariate Information , 1997 .
[13] J Jack Lee,et al. A predictive probability design for phase II cancer clinical trials , 2008, Clinical trials.
[14] Lorenzo Trippa,et al. Bayesian designs and the control of frequentist characteristics: A practical solution , 2015, Biometrics.
[15] James G. Scott,et al. An exploration of aspects of Bayesian multiple testing , 2006 .
[16] D. Berry,et al. Bayesian perspectives on multiple comparisons , 1999 .
[17] D. Berry,et al. Bayesian multiple comparisons using dirichlet process priors , 1998 .
[18] P. O'Brien,et al. A multiple testing procedure for clinical trials. , 1979, Biometrics.
[19] P F Thall,et al. Practical Bayesian guidelines for phase IIB clinical trials. , 1994, Biometrics.
[20] A E Gelfand,et al. Approaches for optimal sequential decision analysis in clinical trials. , 1998, Biometrics.
[21] Christopher Jennison,et al. An improved method for deriving optimal one-sided group sequential tests , 1992 .
[22] Guosheng Yin,et al. Clinical Trial Design: Bayesian and Frequentist Adaptive Methods , 2011 .
[23] A. Labbe,et al. Multiple testing using the posterior probabilities of directional alternatives, with application to genomic studies , 2007 .
[24] A. Tsiatis,et al. Approximately optimal one-parameter boundaries for group sequential trials. , 1987, Biometrics.
[25] Han Zhu,et al. A Bayesian sequential design using alpha spending function to control type I error , 2017, Statistical methods in medical research.
[26] James M. Robins,et al. Semiparametric Efficiency and its Implication on the Design and Analysis of Group-Sequential Studies , 1997 .
[27] R. Dudley,et al. Asymptotic normality with small relative errors of posterior probabilities of half-spaces , 2002 .
[28] D. Berry. Bayesian clinical trials , 2006, Nature Reviews Drug Discovery.
[29] Peter F Thall,et al. Bayesian adaptive model selection for optimizing group sequential clinical trials , 2008, Statistics in medicine.
[30] MENGYE GUO,et al. Multiplicity-calibrated Bayesian hypothesis tests. , 2010, Biostatistics.
[31] P. Thall,et al. Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes. , 1995, Statistics in medicine.
[32] Peter Müller,et al. Bayesian randomized clinical trials: A decision‐theoretic sequential design , 2004 .
[33] Christopher Jennison,et al. Interim analyses: the repeated confidence interval approach , 1989 .
[34] Christopher Jennison,et al. Optimal asymmetric one‐sided group sequential tests , 2002 .
[35] Ying Yuan,et al. Utility‐based designs for randomized comparative trials with categorical outcomes , 2016, Statistics in medicine.
[36] D. Berry. Adaptive clinical trials in oncology , 2012, Nature Reviews Clinical Oncology.
[37] B. Efron. Why Isn't Everyone a Bayesian? , 1986 .
[38] Heinz Schmidli,et al. A practical guide to Bayesian group sequential designs , 2014, Pharmaceutical statistics.
[39] P. Müller,et al. A Bayesian discovery procedure , 2009, Journal of the Royal Statistical Society. Series B, Statistical methodology.
[40] Thomas A Murray,et al. Robust Treatment Comparison Based on Utilities of Semi-Competing Risks in Non-Small-Cell Lung Cancer , 2017, Journal of the American Statistical Association.